CDNA today
$78.21-$1.60 (-2.00%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bearish
1 hourSymmetric Triangle
15 minDescending Triangle
5 minStrong Bearish
Daily trend turns down below $61.19
Key levels
Resistance$90.87
Resistance$81.45
Support$72.51
Support$61.19
Latest news & SEC filings
SEC FilingCareDx, Inc. filed an insider trading report (Form 4)
AnalystPiper Sandler starts CareDx coverage with Overweight rating
AnalystPiper Sandler starts CareDx coverage with Overweight rating and $100 price target
NewsKeith Kennedy, CareDx finance and operations chief, sells $4.8 million in stock
All CDNA news →About CareDx
This company develops blood-based molecular diagnostics for organ transplant recipients. Its tests, sold under names such as AlloSure and AlloMap, help clinicians monitor heart, kidney, and lung grafts for signs of injury or rejection. It also supplies laboratory reagents for tissue matching and stem cell monitoring, plus software and pharmacy support for transplant centers. Customers include transplant clinics, laboratories, and drug developers, mainly across the United States and Europe.
Based on the company's 10-K filed Feb 25, 2026.
Nasdaq · Healthcare
CareDx, Inc. (CDNA)
What Is the Price Target for CDNA?
SEPT Low Target
$68.00
SEPT Mid Target
$80.00
SEPT High Target
$92.00
Analyst Consensus
$80.00
Is CDNA a Buy or Sell Right Now?
Thesis
- •Revenue growing 13.8% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CDNA.
Start Free Trial →Is CDNA Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$67.86
51
Moat Score
NARROW
4/9
Piotroski Score
19.8
Altman Z-Score
What Is Smart Money Doing with CDNA?
Insider Signal
SELLING
0 buys / 9 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Novack Jeffrey Adam | officer | Sale | 2,996 | $241K | Nov 10, 2026 |
| Novack Jeffrey Adam | officer | Sale | 200 | $16K | Nov 10, 2026 |
| Novack Jeffrey Adam | officer | Sale | 900 | $75K | Nov 10, 2026 |
| Bickerstaff George | director | Buy | 15,000 | $221K | Nov 10, 2026 |
| Cohen Fred E | director | Sale | 25,000 | - | Nov 3, 2026 |
| Novack Jeffrey Adam | officer | Sale | 2,873 | $247K | Nov 1, 2026 |
| Goldberg Michael | director | Buy | 588 | - | Oct 2, 2026 |
| Meng Jessica | officer | Sale | 2,619 | $173K | Oct 1, 2026 |
| Novack Jeffrey Adam | officer | Sale | 997 | $66K | Oct 1, 2026 |
| Hanna John Walter JR | director officer | Sale | 8,511 | $564K | Oct 1, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CDNA Growth Story
Revenue YoY
13.8%
3yr Revenue CAGR
5.7%
EPS Growth YoY
-143.01%
FCF Growth YoY
N/A%
Revenue Trend
ACCELERATING
Dark Pool Trades for CDNA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CDNA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 17:02:00 | $77.58 | 1,000 | $$78K | MIDPOINT |
| 16:41:23 | $77.50 | 1,004 | $$78K | SELL |
| 16:41:23 | $77.50 | 2,889 | $$224K | SELL |
| 15:14:30 | $77.63 | 1,651 | $$128K | SELL |
| 15:07:53 | $78.53 | 1,101 | $$86K | MIDPOINT |
5 dark pool trades shown · $$594K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for CareDx, Inc. (CDNA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CDNA — frequently asked questions
What is CDNA stock price today?
CareDx, Inc. (CDNA) is at $78.21, down 2.00% (-$1.60) at the Nov 13, 2026 close.
Why is CDNA stock moving today?
Latest CDNA news — Nov 12, 2026: CareDx, Inc. filed an insider trading report (Form 4) · Nov 11, 2026: Piper Sandler starts CareDx coverage with Overweight rating
What is the CDNA price target?
The average analyst price target for CDNA is $80.00, ranging from $80 to $92, based on 3 analysts. Latest: BTIG maintains on Oct 30, 2026.
What do analysts rate CDNA?
Analyst ratings for CDNA: 1 Buy, 8 Hold, 0 Sell — consensus Hold.
Did CDNA beat earnings?
CDNA last reported on Oct 29, 2026: EPS $0.70 vs $0.25 expected — a beat of 174.7%.
What is CDNA's P/E ratio?
CDNA trades at a P/E of 42.2 vs a Healthcare average of 17.5.
Does CDNA pay a dividend?
CDNA does not currently pay a dividend.
What are CDNA support and resistance levels?
Support: $72.51, $61.19, $53.67. Resistance: $81.45, $90.87, $96.88.
What are insiders doing with CDNA?
Insider activity: SELLING, 0 buys and 9 sells in the last 90 days.
What is the latest news on CDNA?
Nov 12, 2026: CareDx, Inc. filed an insider trading report (Form 4) · Nov 11, 2026: Piper Sandler starts CareDx coverage with Overweight rating · Nov 11, 2026: Piper Sandler starts CareDx coverage with Overweight rating and $100 price target